Vitamin and mineral use and risk of prostate cancer: The case-control surveillance study

Yuqing Zhang, Patricia Coogan, Julie R. Palmer, Brian L. Strom, Lynn Rosenberg

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Background: Many studies have evaluated the association between vitamin and mineral supplement use and the risk of prostate cancer, with inconclusive results. Methods: The authors examined the relation of use of multivitamins as well as several single vitamin and mineral supplements to the risk of prostate cancer risk among 1,706 prostate cancer cases and 2,404 matched controls using data from the hospital-based case-control surveillance study conducted in the United States. Odds ratios (OR) and 95% confidence intervals (CI) for risk of prostate cancer were estimated using conditional logistic regression model. Results: For use of multivitamins that did not contain zinc, the multivariable odds ratios of prostate cancer were 0.6 for 1-4 years, 0.8 for 5-9 years, and 1.2 for 10 years or more, respectively (p for trend = 0.70). Men who used zinc for ten years or more, either in a multivitamin or as a supplement, had an approximately two-fold (OR = 1.9, 95% CI: 1.0, 3.6) increased risk of prostate cancer. Vitamin E, beta-carotene, folate, and selenium use were not significantly associated with increased risk of prostate cancer. Conclusion: The finding that long-term zinc intake from multivitamins or single supplements was associated with a doubling in risk of prostate cancer adds to the growing evidence for an unfavorable effect of zinc on prostate cancer carcinogenesis.

Original languageEnglish (US)
Pages (from-to)691-698
Number of pages8
JournalCancer Causes and Control
Volume20
Issue number5
DOIs
StatePublished - Jul 2009

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Keywords

  • Case-control study multivitamin
  • Prostate neoplasm

Fingerprint Dive into the research topics of 'Vitamin and mineral use and risk of prostate cancer: The case-control surveillance study'. Together they form a unique fingerprint.

Cite this